B. Metzler Seel. Sohn & Co. Ag Teva Pharmaceutical Industries LTD Transaction History
B. Metzler Seel. Sohn & Co. Ag
- $9.53 Billion
- Q4 2024
A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 76,244 shares of TEVA stock, worth $1.26 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
76,244
Previous 25,249
201.97%
Holding current value
$1.26 Million
Previous $454,000
270.04%
% of portfolio
0.02%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TEVA
# of Institutions
674Shares Held
578MCall Options Held
25.5MPut Options Held
14.7M-
Black Rock Inc. New York, NY43MShares$712 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$646 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.7MShares$607 Million48.01% of portfolio
-
Menora Mivtachim Holdings Ltd.28.4MShares$470 Million3.94% of portfolio
-
Exor Capital LLP London, X027.2MShares$451 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.4B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...